{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T09:53:57Z","timestamp":1782899637073,"version":"3.54.5"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"C","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,2]],"date-time":"2014-12-02T00:00:00Z","timestamp":1417478400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2015,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Protein induced by vitamin K absence\/antagonist-II (PIVKA-II) is an abnormal protein, and several reports have demonstrated the efficacy of PIVKA-II in the diagnosis of hepatocellular carcinoma (HCC). We report an extremely rare case of adenocarcinoma of the colon with a high serum PIVKA-II level.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Presentation of Case<\/jats:title>\n                    <jats:p>A 95-year-old woman presented with right lower quadrant pain and appetite loss. An abdominal computed tomography scan and ultrasonography showed an ascending colon tumor and multiple metastatic tumors in the liver. The serum level of PIVKA-II was extremely high, 11,900 ng\/mL. Colonoscopic examination revealed a tumor accompanied by an ulcer in the ascending colon, which was highly suspicious for malignancy. Multiple biopsies showed well-differentiated adenocarcinoma of the colon, which was evaluated as colon cancer, stage IV. PIVKA-II-productive colon cancer was confirmed. Chemotherapy with TS-1 was administered. The patient died 3 months after initial admission.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>The expression of PIVKA-II was detected in non-cancer areas, with non-specific expression observed in plasma cells in our case. There might be some possibility that hepatoid differentiation exists in other regions of the colon tumor or in the liver tumor, parenchymal cells or lung metastases, which were composed of PIVKA-II-positive and AFP-negative cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>To the best of our knowledge, high serum levels of PIVKA-II resulting from colon adenocarcinoma have not been reported previously. We report this rare case together with a review of the literature.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Highlights<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1016\/j.ijscr.2014.11.072","type":"journal-article","created":{"date-parts":[[2014,12,4]],"date-time":"2014-12-04T19:03:33Z","timestamp":1417719813000},"page":"95-99","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Primary colon cancer with a high serum PIVKA-II level"],"prefix":"10.1097","volume":"6","author":[{"given":"Kazuya","family":"Kato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Iwasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Onodera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takako","family":"Kawakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mineko","family":"Higuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimitaka","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yurina","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-28-20260114","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1056\/NEJM198405313102204","article-title":"Des-gamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma","volume":"310","author":"Liebman","year":"1984","journal-title":"N. Engl. J. Med"},{"key":"R2-28-20260114","first-page":"1859","article-title":"Des-gamma-carboxy prothrombin (PIVKA-II) and alpha-fetoprotein-producing IIc-type early gastric cancer","volume":"87","author":"Kudo","year":"1992","journal-title":"Am. J. Gastroenterol"},{"key":"R3-28-20260114","first-page":"4569","article-title":"Des-g-carboxy Prothrombin (PIVKA II)-producing mediastinal embryonal carcinoma with features of hepatoid differentiation","volume":"25","author":"Hasegawa","year":"2005","journal-title":"Anticancer Res"},{"key":"R4-28-20260114","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1146\/annurev.bi.46.070177.001105","article-title":"Vitamin K-dependent formation of gamma-carboxyglutamic acid","volume":"46","author":"Stenflo","year":"1977","journal-title":"Annu. Rev. Biochem"},{"key":"R5-28-20260114","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/hep.1840110321","article-title":"Plasma des-gamma-carboxyprothrombin in the early stage of hepatocellular carcinoma","volume":"11","author":"Tsai","year":"1990","journal-title":"Hepatology"},{"key":"R6-28-20260114","first-page":"1036","article-title":"Stimulus measurements of serum alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellualar carcinoma, South Tohoku District Study Group","volume":"95","author":"Ishii","year":"2000","journal-title":"Am. J. Gastroenterol"},{"key":"R7-28-20260114","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/1097-0142(20010201)91:3<561::AID-CNCR1035>3.0.CO;2-N","article-title":"Protein induced by vitamin K absence or antagonist-II as useful predisposing factor for the development of portal venous invasion in patients with hepatocellular carcinoma. A prospective analysis of 227 patients","volume":"91","author":"Koike","year":"2001","journal-title":"Cancer"},{"key":"R8-28-20260114","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1002\/1097-0142(19940515)73:10<2464::AID-CNCR2820731004>3.0.CO;2-9","article-title":"Protein induced by vitamin K absence or antagonist II as a prognostic marker in hepatocellular carcinoma, Comparison with alpha-fetoprotein","volume":"73","author":"Suehiro","year":"1994","journal-title":"Cancer"},{"key":"R9-28-20260114","doi-asserted-by":"crossref","first-page":"8741","DOI":"10.1074\/jbc.M609358200","article-title":"Des-gamma-carboxy prothrombin-promoted vascular endothelial cell proliferation and migration","volume":"282","author":"Fujikawa","year":"2007","journal-title":"J. Biol. Chem"},{"key":"R10-28-20260114","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1002\/1097-0142(19940901)74:5<1533::AID-CNCR2820740507>3.0.CO;2-V","article-title":"Mechanism of the abnormal vitamin K-dependent gamma-carboxylation process in human hepatocellular carcinomas","volume":"74","author":"Huisse","year":"1994","journal-title":"Cancer"},{"key":"R11-28-20260114","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4291\/wjgp.v1.i4.129","article-title":"Protein induced by vitamin K absence or antagonist II-producing gastric cancer","volume":"15","author":"Takahashi","year":"2010","journal-title":"World J. Gastrointest Pathophysiol"},{"key":"R12-28-20260114","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1002\/1097-0142(19940401)73:7<1919::AID-CNCR2820730724>3.0.CO;2-L","article-title":"Hepatoid adenocarcinoma in the urinary bladder: Unusual localization of a newly recognized tumor type","volume":"73","author":"Sinard","year":"1994","journal-title":"Cancer"},{"key":"R13-28-20260114","first-page":"1045","article-title":"Colon cancer with a high serum alpha-fetoprotein level","volume":"91","author":"Kato","year":"1996","journal-title":"Am. J. Gastroenterol"},{"key":"R14-28-20260114","first-page":"969","article-title":"Des-r-carboxy prothrombin in cancer and non-cancer liver tissue of patients with hepatocellular carcinoma","volume":"22","author":"Tang","year":"2003","journal-title":"Int. J. Oncol"},{"key":"R15-28-20260114","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1002\/1097-0142(19930915)72:6<1827::AID-CNCR2820720606>3.0.CO;2-8","article-title":"Hepatoid adenocarcinoma of the stomach: a clinicopathologic and immunohistochemical analysis","volume":"72","author":"Nagai","year":"1993","journal-title":"Cancer"},{"key":"R16-28-20260114","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s10147-004-0398-0","article-title":"PIVKA-II-producing advanced gastric cancer","volume":"9","author":"Takano","year":"2004","journal-title":"Int. J. Clin. Oncol"},{"key":"R17-28-20260114","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1200\/JCO.2001.19.6.1865","article-title":"2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology","volume":"19","author":"Bast","year":"2001","journal-title":"J. Clin. Oncol"},{"key":"R18-28-20260114","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/BF01542654","article-title":"Colorectal carcinoma antigens detected by hybridoma antibodies","volume":"5","author":"Koprowski","year":"1979","journal-title":"Somatic Cell Genet"},{"key":"R19-28-20260114","first-page":"991","article-title":"Serum \u03b1-fetoprotein in patients with neoplasms of the gastrointestinal tract","volume":"35","author":"Mclntire","year":"1975","journal-title":"Cancer Res"},{"key":"R20-28-20260114","doi-asserted-by":"crossref","first-page":"543","DOI":"10.2174\/187152011796011109","article-title":"Therapeutic potential of targeting glypiacn-3 hepatocelluar carcinoma","volume":"11","author":"Allegretta","year":"2011","journal-title":"Anticancer agents Med. Chem"}],"container-title":["International Journal of Surgery Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210261214004246?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210261214004246?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01612930-201506000-00028","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T13:36:53Z","timestamp":1768397813000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01612930-201506000-00028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":20,"journal-issue":{"issue":"C","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1016\/j.ijscr.2014.11.072","relation":{},"ISSN":["2210-2612"],"issn-type":[{"value":"2210-2612","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]}}}